| | | Results of HI test [2] . | | | | | Antisera to: |
|---|
| Antigens | Karimabad | Tehran | Naples | Sicilian | Salehabad |
|---|
|
| | a HI titers with 8 HA units of antigen; 0 = <1:20 | | Karimabad | 640 a | 0 | 40 | 0 | 80 | | Tehran | 640 | 320 | 640 | 0 | 80 | | Naples | 640 | 160 | 1280 | 0 | 20 | | Sicilian | 40 | 0 | 0 | 1280 | 0 | | Salehabad | 320 | 0 | 20 | 0 | 320 |
| | Results of CF and plaque-reduction neutralization tests (PRNT) [4] . | | | | | CF | PRNT |
|---|
| | Antibody to: | Antibody to: |
|---|
| Antigen/Virus | Naples | ISS.Phl.3 | Tehran | Naples | ISS.Phl.3 | Tehran |
|---|
|
| | b Highest serum titer/highest antigen titer | | c Reciprocal of highest serum dilution giving >90% plaque reduction. | | Naples | 256/128 b | 64/64 | 128/128 | 320 c | 10 | <10 | | ISS.Phl.3 | 128/256 | 256/> 512 | 128/256 | 20 | > 5120 | <10 | | Tehran | 128/64 | 64/64 | 256/128 | <10 | <10 | 80 |
| | In cross-neut. tests, Tehran virus and immune serum did not react with: AGU, ALE, ANH, AMT, BUE, BUJ, CAC, CAI, CDU, CHG, CHI, FRI, GF, GOR, ICO, ITA, ITP, KAR, NIQ, PAC, PT, RVF, RG, SAF, SAL, SFS, TRA, or URU viruses or immune sera [4] . | | |
|